CPHI [CHINA PHARMAS,] PRER14C: SCHEDULE 14C INFORMATION Amendment No. 2 I Check

[SCHEDULE 14C INFORMATION Amendment No. 2 I Check the appropriate box: [X] Preliminary Information Statement [] [] Definitive Information Statement CHINA PHARMAS, Payment of Filing Fee (Check the appropriate box): [X] No fee required. [] Feemputed on table below per Exchange Act Rules 14c-5(g) and 0-11. 1) Title of each class of securities to which] [April 30, 2010 Division ofrporation Finance 100 F Street N.E. Attn: Bryan Pitko Re: China Pharmas, Revised Preliminary Information Statement on Form PRE 14C Filed April 1, 2010 File No.001-34471 Dear Mr. Bryan Pitko,mpanymment Letter Form PRER 14C On behalf of China Pharmas, a Delawarerporation (the]

By | 2016-02-07T23:33:19+00:00 April 30th, 2010|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals,] 8-K: (Original Filing)

[BIOSTAR PHARMACEUTICALS, INC. RECEIVES NEW ADVERTISING APPROVAL FROM SHAANXI SFDA FOR MARKETING XIN AOXING CAPSULE XIANYANG, China, April 27, 2010 (Xinhua-PRNewswire-FirstCall) On April 22, 2010 the Shaanxi SFDA published on its website a notification stating that the marketing language used in connection with several pharmaceutical products sold in the province are not within approved parameters. Biostar Pharmaceuticals’ flagship Hepatitis B]

By | 2016-03-03T14:33:54+00:00 April 28th, 2010|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals,] 8-K: BIOSTAR PHARMACEUTICALS, INC. RECEIVES NEW ADVERTISING APPROVAL FROM

[BIOSTAR PHARMACEUTICALS, INC. RECEIVES NEW ADVERTISING APPROVAL FROM SHAANXI SFDA FOR MARKETING XIN AOXING CAPSULE XIANYANG, China, April 27, 2010 (Xinhua-PRNewswire-FirstCall) On April 22, 2010 the Shaanxi SFDA published on its website a notification stating that the marketing language used in connection with several pharmaceutical products sold in the province are not within approved parameters. Biostar Pharmaceuticals’ flagship Hepatitis B]

By | 2016-03-03T14:36:01+00:00 April 28th, 2010|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals,] 8-K: (Original Filing)

[BIOSTAR PHARMACEUTICALS, RECEIVES NEWVERTISING APPROVAL FROM SHAANXI SFDA FOR MARKETING XIN AOXINGPSULE XIANYANG, China, April 27, 2010 (Xinhua-PRNewswire-FirstCall) On April 22, 2010 the Shaanxi SFDA published on its website a notification stating that the marketing language used innnection with several pharmaceutical products sold in the province are not within approved parameters.Biostar Pharmaceuticals flagship Hepatitis B]

By | 2016-02-07T17:30:24+00:00 April 28th, 2010|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals,] 8-K: BIOSTAR PHARMACEUTICALS, RECEIVES NEWVERTISING APPROVAL FROM SHAANXI SFDA

[BIOSTAR PHARMACEUTICALS, RECEIVES NEWVERTISING APPROVAL FROM SHAANXI SFDA FOR MARKETING XIN AOXINGPSULE XIANYANG, China, April 27, 2010 (Xinhua-PRNewswire-FirstCall) On April 22, 2010 the Shaanxi SFDA published on its website a notification stating that the marketing language used innnection with several pharmaceutical products sold in the province are not within approved parameters.Biostar Pharmaceuticals flagship Hepatitis B]

By | 2016-02-07T17:31:04+00:00 April 28th, 2010|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments

WX [WuXi PharmaTech (Cayman)] SC 13D/A: (Original Filing)

[EXECUTION COPY VOTING AGREEMENT “Acquiror” Shareholder Shareholders AGREEMENT, dated as of April 26, 2010 between Charles River Laboratories International, Inc., a Delaware corporation ( Acquisition Agreemen Company Shares ADSs provided WHEREAS, in order to induce Acquiror to enter into an Agreement and Plan of Arrangement, dated as of the date hereof (the “ NOW, THEREFORE, the parties hereto agree as] []

By | 2016-04-02T20:12:36+00:00 April 27th, 2010|Categories: Chinese Stocks, SEC Original, WX|Tags: , , , , , |0 Comments

WX [WuXi PharmaTech (Cayman)] SC 13D/A: EXECUTION COPY VOTING AGREEMENT “Acquiror” Shareholder Shareholders AGREEMENT,

[EXECUTION COPY VOTING AGREEMENT “Acquiror” Shareholder Shareholders AGREEMENT, dated as of April 26, 2010 between Charles River Laboratories International, Inc., a Delaware corporation ( Acquisition Agreemen Company Shares ADSs provided WHEREAS, in order to induce Acquiror to enter into an Agreement and Plan of Arrangement, dated as of the date hereof (the “ NOW, THEREFORE, the parties hereto agree as] []

By | 2016-04-02T20:13:47+00:00 April 27th, 2010|Categories: Chinese Stocks, Webplus ver, WX|Tags: , , , , , |0 Comments
Skip to toolbar